News

01/09/2019

Dickinson Williams advises Catalyst Clinical Research on its sale to NovaQuest Capital Management

Dickinson Williams & Company serves as the exclusive financial advisor to Catalyst Clinical Research, LLC on its sale to NovaQuest Capital Management’s private equity group.  Catalyst Clinical Research is a niche contract research organization that specializes in providing highly tailored clinical operations solutions to the global biopharmaceutical and medical device industries.

“Dickinson Williams has truly enjoyed working with the entire Catalyst team to properly position the business and find the right partner,” said James Gilmore, Managing Director of Dickinson Williams & Co.  “As industry veterans, they have thoughtfully built a business that addresses the complex clinical operations needs of their clients while emphasizing the importance of collaborative relationships.  We look forward to seeing Catalyst continue to grow alongside NovaQuest.”

“The team at Dickinson Williams executed a disciplined process and kept us on track. They were committed to ensuring our success, providing coaching and management throughout the entire process. It was advantageous to have them on our team,” said Jean Hendrickson, Catalyst’s Co-founder.

James M. O’Connell, PLLC served as the legal advisor to Catalyst Clinical. Research on the transaction.

About Catalyst Clinical Research, LLC

Headquartered in Durham, North Carolina, Catalyst is a leading provider of clinical operations solutions to the biotechnology, pharmaceutical and medical device companies for clinical research programs.  With locations in the US and UK, the company serves many global companies, providing customer-centric solutions on a worldwide basis.  The company was built on more than two decades of experience in assisting clients with their clinical development programs by providing therapeutically aligned experts and teams using customized solutions.  For more information, please visit www.catalystcr.com.

About NovaQuest Capital Management, LLC

NovaQuest Capital Management is a leading investor in life sciences and healthcare through its BioPharma and Private Equity strategies. NovaQuest was formed in 2000 with the vision of building an investment platform to provide strategic capital to life sciences and healthcare companies. Today, NovaQuest Capital Management manages over $1.8 billion. The investment team consists of highly seasoned professionals with significant operating and investment experience and deep life science and healthcare expertise. Furthermore, NovaQuest benefits from an extensive network of industry experts and relationships that assist in identifying, analyzing and growing portfolio companies and investments. For more information, please visit www.novaquest.com.

About Dickinson Williams & Company:

Dickinson Williams & Company is an independent investment banking firm led by industry veterans with over 80 years of combined investment banking, financing, and operating experience.  The firm provides objective, experience-based advisory services to lower middle market companies with enterprise values typically up to $150 million.  The firm provides sell-side, buy-side, private placement, recapitalization, and strategic advisory services to family and closely held businesses, corporations, and private equity groups, and has a broad cross-section of transaction and industry experience in the industrials, business services, distribution, healthcare, and consumer sectors.

John C. Dickinson
Managing Director
jdickinson@dickinsonwilliams.com
804.588.3412

James A. Gilmore
Managing Director
jgilmore@dickinsonwilliams.com
804.588.3414

Harold J. Williams III
Managing Director
hwilliams@dickinsonwilliams.com
804.588.3413

Recent News

07/28/2022

Dickinson Williams & Co. Announces Three New Hires to Support Growth

Dickinson Williams & Company is pleased to announce that it has added an Associate and two Analysts to its team.…

02/22/2022

Dickinson Williams advises on the sale of South Jersey Paper Products

Dickinson Williams & Company served as the exclusive financial advisor to South Jersey Paper Products, Inc. (“SJP”) in its sale…

01/25/2022

Dickinson Williams advises on the sale of Fi-Foil Company

Dickinson Williams & Company served as the exclusive financial advisor to Fi-Foil Company, Inc. (“Fi-Foil”) in its sale to Validor…